LUPUS ERYTHEMATOSUS, SYSTEMIC
Clinical trials for LUPUS ERYTHEMATOSUS, SYSTEMIC explained in plain language.
Never miss a new study
Get alerted when new LUPUS ERYTHEMATOSUS, SYSTEMIC trials appear
Sign up with your email to follow new studies for LUPUS ERYTHEMATOSUS, SYSTEMIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New lupus drug shows promise in major trial
Disease control OngoingThis study tests a new drug called litifilimab for people with active systemic lupus erythematosus (SLE), a chronic autoimmune disease. About 562 adults already on standard lupus treatments will receive either litifilimab or a placebo as a shot every 4 weeks for a year. The goal …
Matched conditions: LUPUS ERYTHEMATOSUS, SYSTEMIC
Phase: PHASE3 • Sponsor: Biogen • Aim: Disease control
Last updated May 26, 2026 10:33 UTC
-
New hope for lupus patients: phase 3 trial of cenerimod launches
Disease control OngoingThis study tests whether adding cenerimod to standard lupus treatments can better control symptoms in adults with moderate-to-severe systemic lupus erythematosus (SLE). About 470 participants will receive either cenerimod or a placebo for 12 months. The goal is to see if cenerimo…
Matched conditions: LUPUS ERYTHEMATOSUS, SYSTEMIC
Phase: PHASE3 • Sponsor: Viatris Innovation GmbH • Aim: Disease control
Last updated May 26, 2026 10:32 UTC
-
New lupus drug shows promise in major trial
Disease control OngoingThis study tests whether adding cenerimod to standard lupus treatments can better control symptoms in adults with moderate-to-severe lupus. About 451 participants will receive either cenerimod or a placebo for 12 months. The goal is to see if cenerimod reduces disease activity wi…
Matched conditions: LUPUS ERYTHEMATOSUS, SYSTEMIC
Phase: PHASE3 • Sponsor: Viatris Innovation GmbH • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
New lupus drug tested for Long-Term safety in 680 patients
Disease control ENROLLING_BY_INVITATIONThis study looks at the long-term safety of cenerimod in adults with moderate-to-severe systemic lupus erythematosus (SLE). About 680 participants who completed a previous year-long study will take cenerimod on top of their usual lupus medications for up to 3 years. Researchers w…
Matched conditions: LUPUS ERYTHEMATOSUS, SYSTEMIC
Phase: PHASE3 • Sponsor: Viatris Innovation GmbH • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
New lupus drug shows promise in major trial
Disease control OngoingThis study tests a new drug called litifilimab for people with active systemic lupus erythematosus (SLE), a chronic autoimmune disease. About 548 adults already on standard lupus treatments will receive either litifilimab or a placebo as a shot every 4 weeks for a year. The goal …
Matched conditions: LUPUS ERYTHEMATOSUS, SYSTEMIC
Phase: PHASE3 • Sponsor: Biogen • Aim: Disease control
Last updated May 18, 2026 12:09 UTC
-
New lupus drug saphnelo tracked in Real-World study
Disease control OngoingThis study follows 1620 lupus patients who are not responding well to current treatments to see how safe and effective Saphnelo (anifrolumab) is over the long term. Researchers will monitor for side effects like infections and allergic reactions. The goal is to gather real-world …
Matched conditions: LUPUS ERYTHEMATOSUS, SYSTEMIC
Sponsor: AstraZeneca • Aim: Disease control
Last updated May 18, 2026 12:08 UTC
-
Pilates put to the test: could gentle exercise ease lupus fatigue?
Symptom relief ENROLLING_BY_INVITATIONThis study looks at whether clinical Pilates exercises can help women with lupus feel less tired, improve their mood, sleep better, and have a better quality of life. About 30 women with stable, low-activity lupus will take part. The goal is to see if this gentle exercise program…
Matched conditions: LUPUS ERYTHEMATOSUS, SYSTEMIC
Phase: NA • Sponsor: Emir İbrahim IŞIK • Aim: Symptom relief
Last updated May 26, 2026 10:31 UTC
-
Lupus fatigue fight: coaching shows promise
Symptom relief OngoingThis study tests whether personalized coaching on physical activity and nutrition can reduce fatigue in people with lupus. 200 participants are split into two groups: one gets coaching on exercise and diet, the other gets general lupus education. The goal is to see if the coachin…
Matched conditions: LUPUS ERYTHEMATOSUS, SYSTEMIC
Phase: NA • Sponsor: Northwestern University • Aim: Symptom relief
Last updated May 26, 2026 10:23 UTC
-
New online program aims to keep arthritis patients working
Symptom relief OngoingThis study tests an online program designed to help people with inflammatory arthritis stay employed. About 528 adults with conditions like rheumatoid arthritis or lupus will either use the program or receive standard care and printed materials. The program includes eLearning and…
Matched conditions: LUPUS ERYTHEMATOSUS, SYSTEMIC
Phase: NA • Sponsor: University of British Columbia • Aim: Symptom relief
Last updated May 22, 2026 14:01 UTC
-
Can a smartphone app help teens with lupus fight depression and stay on track?
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at how depression symptoms, like loss of interest, may cause teens and young adults with lupus to skip medical appointments. Researchers will test a mobile health app designed to improve clinic attendance and mood. About 40 participants aged 15-24 from the Bronx …
Matched conditions: LUPUS ERYTHEMATOSUS, SYSTEMIC
Phase: NA • Sponsor: Montefiore Medical Center • Aim: Knowledge-focused
Last updated May 26, 2026 10:33 UTC
-
Scientists compare immune cells to unlock disease secrets
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at immune cells from people with autoimmune diseases, infectious diseases, and healthy volunteers. Researchers want to understand how these cells differ. The goal is to learn more about how the immune system works in different conditions. Up to 2,500 people will …
Matched conditions: LUPUS ERYTHEMATOSUS, SYSTEMIC
Sponsor: Emory University • Aim: Knowledge-focused
Last updated May 26, 2026 10:25 UTC